David Charles

Vanderbilt University — United States

Medicine · Health Sciences

37h-index4.5kcitations304works0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurological disorders and treatments(110), Botulinum Toxin and Related Neurological Disorders(98), Parkinson's Disease Mechanisms and Treatments(63), Genetic Neurodegenerative Diseases(30), Stroke Rehabilitation and Recovery(18)

Publications304 total

(187) Shifting Patterns in Rear Tip Extender Use During Inflatable Penile Prosthesis Surgery
The Journal of Sexual Medicine·2025Open Access
<scp>ENLITE PD:</scp> A Randomized Clinical Trial of Light Therapy for Impaired Sleep in Parkinson's Disease
Movement Disorders·2025
Utilization Management and Physician Burnout
The American Journal of Managed Care·2024· 1 cited
Phosphatidylserine-Positive Live Sperm as a Biomarker of Fertility Status: Evidence from Patients Undergoing Varicocele Treatment
JU Open Plus·2024· 2 citedOpen Access
Treatment response to onabotulinumtoxinA in cervical dystonia patients with anterocollis and retrocollis
Toxicon·2024· 3 citedOpen Access
PO-05-052 OUTFLOW TRACT VENTRICULAR TACHYCARDIA STORM AS A PRESENTATION OF SADDLE PULMONARY EMBOLISM
Heart Rhythm·2024· 2 citedOpen Access
Can a specific deep brain stimulation paradigm slow motor progression and provide long-term motor benefit in Parkinson’s disease?
Parkinsonism & Related Disorders·2024
Telehealth Follow-up for Cervical Dystonia Patients Treated with Neurotoxin Injection: Patient Reported Outcomes
Parkinsonism & Related Disorders·2024
PD53-04 PHOSPHATIDYLSERINE POSITIVE (PS <sup>+</sup> ) LIVE SPERM: AN INDICATOR OF FERTILITY IN PATIENTS WITH VARICOCELE
The Journal of Urology·2024
Evaluating a Motor Progression Connectivity Model Across Parkinson’s Disease Stages
2024Open Access
(308) Vasectomy Regret: Is Having Children Protective?
The Journal of Sexual Medicine·2024Open Access
Injections of incobotulinumtoxina at intervals less than 10 weeks are effective and safe for cervical dystonia patients with inadequate benefit from standard injection intervals
Journal of the Neurological Sciences·2023Open Access
Treatment of cervical dystonia using shorter incobotulinumtoxina injection intervals improves patient-reported outcomes in those with inadequate benefits from standard intervals
Journal of the Neurological Sciences·2023Open Access
The Efficacy of Hospice-In-Place Care Versus Traditional Inpatient Care
American Journal of Hospice and Palliative Medicine®·2023· 1 citedOpen Access
Preface
2023
Treatment of cervical dystonia using shorter incobotulinumtoxinA injection intervals improves patient-reported outcomes in those with inadequate benefits from standard intervals
Parkinsonism & Related Disorders·2023
Eleven-year outcomes from the deep brain stimulation in early-stage Parkinson’s disease pilot clinical trial
Parkinsonism & Related Disorders·2023
IncobotulinumtoxinA injections at intervals &lt;10 weeks are effective and safe for cervical dystonia patients with inadequate benefit from standard intervals
Parkinsonism & Related Disorders·2023
Long-term neuropsychological outcomes of deep brain stimulation in early-stage Parkinson's disease
Parkinsonism & Related Disorders·2023· 8 citedOpen Access
Connectivity Profile for Subthalamic Nucleus Deep Brain Stimulation in Early Stage Parkinson Disease
Annals of Neurology·2023· 26 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

Thomas L. Davis(17), Peter E. Konrad(14), Peter Hedera(11), Fenna T. Phibbs(10), Joseph S. Neimat(8), Chandler E. Gill(7), Mallory L. Hacker(6), Joseph Jankovic(5), Maxim Turchan(5), Lauren E. Heusinkveld(5), Anna Lia Molinari(5), Mitchell F. Brin(5), Cynthia Comella(4), Amanda Currie(4), Michael G. Tramontana(4), Charles H. Adler(4), Mark Stacy(4), Marc Schwartz(4), Kevin R. Cannard(3), Chris Kao(3)